These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Cutaneous manifestations of the COVID-19 pandemic in schoolchildren and adolescents. Franulić D; Parać E; Dolački L; Topalušić I; Lugović-Mihić L Acta Dermatovenerol Alp Pannonica Adriat; 2023 Dec; 32(4):173-181. PubMed ID: 38126100 [TBL] [Abstract][Full Text] [Related]
47. Chilblain-Like Lesions (CLL) Coinciding With the SARS-CoV-2 Pandemic in Children: A Systematic Review. Starkey SY; Kashetsky N; Lam JM; Dutz J; Mukovozov IM J Cutan Med Surg; 2023; 27(3):277-284. PubMed ID: 37340564 [TBL] [Abstract][Full Text] [Related]
48. Histopathologic Features of Chilblainlike Lesions Developing in the Setting of the Coronavirus Disease 2019 (COVID-19) Pandemic. Sohier P; Matar S; Meritet JF; Laurent-Roussel S; Dupin N; Aractingi S Arch Pathol Lab Med; 2021 Feb; 145(2):137-144. PubMed ID: 33501498 [TBL] [Abstract][Full Text] [Related]
49. Chilblain or perniosis-like skin lesions in children during the COVID-19 pandemic: A systematic review of articles. Molaee H; Emadi SN; M Imunya JMN; Davoudi-Monfared E; Mohammed A; Razavi Z Dermatol Ther; 2022 Mar; 35(3):e15298. PubMed ID: 34981615 [TBL] [Abstract][Full Text] [Related]
50. Cutaneous manifestations of SARS-CoV-2 infection: a clinical update. Gisondi P; PIaserico S; Bordin C; Alaibac M; Girolomoni G; Naldi L J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2499-2504. PubMed ID: 32585074 [TBL] [Abstract][Full Text] [Related]
51. Covid-19 pandemic and the skin. Drenovska K; Schmidt E; Vassileva S Int J Dermatol; 2020 Nov; 59(11):1312-1319. PubMed ID: 32954488 [TBL] [Abstract][Full Text] [Related]
52. Paraviral eruptions in the era of COVID-19: Do some skin manifestations point to a natural resistance to SARS-CoV-2? Lipsker D Clin Dermatol; 2020; 38(6):757-761. PubMed ID: 33341210 [TBL] [Abstract][Full Text] [Related]
53. Chilblain-like lesions in children following suspected COVID-19 infection. Colonna C; Monzani NA; Rocchi A; Gianotti R; Boggio F; Gelmetti C Pediatr Dermatol; 2020 May; 37(3):437-440. PubMed ID: 32374033 [TBL] [Abstract][Full Text] [Related]
54. Cutaneous manifestations in a series of 417 patients with SARS-CoV-2 infection: epidemiological and clinical correlates of chilblain like lesions. Brancaccio G; Gussetti N; Sasset L; Alaibac M; Tarantello M; Salmaso R; Trevenzoli M; Cattelan AM Pathog Glob Health; 2021; 115(7-8):483-486. PubMed ID: 33729097 [TBL] [Abstract][Full Text] [Related]
55. Do we have serological evidences that chilblain-like lesions are related to SARS-CoV-2? A review of the literature. Balestri R; Magnano M; Rizzoli L; Rech G Dermatol Ther; 2020 Nov; 33(6):e14229. PubMed ID: 32844512 [TBL] [Abstract][Full Text] [Related]
56. Cutaneous manifestations in children with SARS-CoV-2 infection and/or COVID-19: what do we know after 10 months under this pandemic? Li H; Zhao Y; Zhou L Int J Dermatol; 2022 Jan; 61(1):39-45. PubMed ID: 34530491 [TBL] [Abstract][Full Text] [Related]
57. Cutaneous manifestations of COVID-19 in Mexican patients: A case series and review of literature. Palomo-Pérez JC; Vega-Memije ME; Aguilar-Blancas D; González-Martínez E; Rangel-Gamboa L SAGE Open Med Case Rep; 2021; 9():2050313X21997194. PubMed ID: 33747514 [TBL] [Abstract][Full Text] [Related]
58. A comprehensive narrative review of the cutaneous manifestations associated with COVID-19. Arefinia N; Ghoreshi ZA; Alipour AH; Iranmanesh B; Mehrolhasani N; Shamsi-Meymandi S; Sarvari J Int Wound J; 2023 Mar; 20(3):871-879. PubMed ID: 36237171 [TBL] [Abstract][Full Text] [Related]
59. No evidence of SARS-CoV-2 infection by polymerase chain reaction or serology in children with pseudo-chilblain. Caselli D; Chironna M; Loconsole D; Nigri L; Mazzotta F; Bonamonte D; Aricò M Br J Dermatol; 2020 Oct; 183(4):784-785. PubMed ID: 32613638 [No Abstract] [Full Text] [Related]